| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $405.5M | +4.6% |
| Cost of Revenue | $233.8M | -2.5% |
| Gross Profit | $171.7M | +16.3% |
| R&D Expense | $33.7M | -6.9% |
| SG&A Expense | $58.2M | -14.7% |
| Operating Income | $32.7M | +242.4% |
| Pre-tax Income | $56.3M | +441.5% |
| Income Tax | $2.6M | +78.5% |
| Net Income | $53.7M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $290.4M | +245.8% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $40.2M | -43.3% |
| Inventory | $47.6M | -50.5% |
| Current Assets | $386.5M | +18.6% |
| Total Assets | $482.8M | +8.6% |
| Current Liabilities | $39.5M | -43.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $141.6M | +400.0% |
| Capital Expenditures | $5.8M | -14.3% |
| Investing Cash Flow | $66.2M | +213.7% |
| Financing Cash Flow | -$3.0M | +21.0% |
| Free Cash Flow | $135.8M | +351.6% |
| +399.2% |
| EPS (Basic) | $0.73 | +392.0% |
| EPS (Diluted) | $0.72 | +388.0% |
| Total Liabilities |
| $52.2M |
| -35.7% |
| Stockholders' Equity | $430.7M | +18.4% |